247 related articles for article (PubMed ID: 31936544)
1. Crocetin Extracted from Saffron Shows Antitumor Effects in Models of Human Glioblastoma.
Colapietro A; Mancini A; Vitale F; Martellucci S; Angelucci A; Llorens S; Mattei V; Gravina GL; Alonso GL; Festuccia C
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31936544
[TBL] [Abstract][Full Text] [Related]
2. Bortezomib inhibits growth and sensitizes glioma to temozolomide (TMZ) via down-regulating the FOXM1-Survivin axis.
Tang JH; Yang L; Chen JX; Li QR; Zhu LR; Xu QF; Huang GH; Zhang ZX; Xiang Y; Du L; Zhou Z; Lv SQ
Cancer Commun (Lond); 2019 Dec; 39(1):81. PubMed ID: 31796105
[TBL] [Abstract][Full Text] [Related]
3. The first-in-class alkylating deacetylase inhibitor molecule tinostamustine shows antitumor effects and is synergistic with radiotherapy in preclinical models of glioblastoma.
Festuccia C; Mancini A; Colapietro A; Gravina GL; Vitale F; Marampon F; Delle Monache S; Pompili S; Cristiano L; Vetuschi A; Tombolini V; Chen Y; Mehrling T
J Hematol Oncol; 2018 Feb; 11(1):32. PubMed ID: 29486795
[TBL] [Abstract][Full Text] [Related]
4. The antileukemic effects of saffron (Crocus sativus L.) and its related molecular targets: A mini review.
Moradzadeh M; Kalani MR; Avan A
J Cell Biochem; 2019 Apr; 120(4):4732-4738. PubMed ID: 30644127
[TBL] [Abstract][Full Text] [Related]
5. Antitumor effects of saffron-derived carotenoids in prostate cancer cell models.
Festuccia C; Mancini A; Gravina GL; Scarsella L; Llorens S; Alonso GL; Tatone C; Di Cesare E; Jannini EA; Lenzi A; D'Alessandro AM; Carmona M
Biomed Res Int; 2014; 2014():135048. PubMed ID: 24900952
[TBL] [Abstract][Full Text] [Related]
6. Anti-tumor effects of crocetin and related molecular targets.
Moradzadeh M; Sadeghnia HR; Tabarraei A; Sahebkar A
J Cell Physiol; 2018 Mar; 233(3):2170-2182. PubMed ID: 28407293
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of radiosensitivity by the novel anticancer quinolone derivative vosaroxin in preclinical glioblastoma models.
Gravina GL; Mancini A; Mattei C; Vitale F; Marampon F; Colapietro A; Rossi G; Ventura L; Vetuschi A; Di Cesare E; Fox JA; Festuccia C
Oncotarget; 2017 May; 8(18):29865-29886. PubMed ID: 28415741
[TBL] [Abstract][Full Text] [Related]
8. Crocetin inhibits pancreatic cancer cell proliferation and tumor progression in a xenograft mouse model.
Dhar A; Mehta S; Dhar G; Dhar K; Banerjee S; Van Veldhuizen P; Campbell DR; Banerjee SK
Mol Cancer Ther; 2009 Feb; 8(2):315-23. PubMed ID: 19208826
[TBL] [Abstract][Full Text] [Related]
9. Afatinib and Temozolomide combination inhibits tumorigenesis by targeting EGFRvIII-cMet signaling in glioblastoma cells.
Vengoji R; Macha MA; Nimmakayala RK; Rachagani S; Siddiqui JA; Mallya K; Gorantla S; Jain M; Ponnusamy MP; Batra SK; Shonka N
J Exp Clin Cancer Res; 2019 Jun; 38(1):266. PubMed ID: 31215502
[TBL] [Abstract][Full Text] [Related]
10. Intratumoral delivery of bortezomib: impact on survival in an intracranial glioma tumor model.
Wang W; Cho HY; Rosenstein-Sisson R; Marín Ramos NI; Price R; Hurth K; Schönthal AH; Hofman FM; Chen TC
J Neurosurg; 2018 Mar; 128(3):695-700. PubMed ID: 28409734
[TBL] [Abstract][Full Text] [Related]
11. Crocetin and Crocin from Saffron in Cancer Chemotherapy and Chemoprevention.
Colapietro A; Mancini A; D'Alessandro AM; Festuccia C
Anticancer Agents Med Chem; 2019; 19(1):38-47. PubMed ID: 30599111
[TBL] [Abstract][Full Text] [Related]
12. The novel CXCR4 antagonist, PRX177561, reduces tumor cell proliferation and accelerates cancer stem cell differentiation in glioblastoma preclinical models.
Gravina GL; Mancini A; Colapietro A; Vitale F; Vetuschi A; Pompili S; Rossi G; Marampon F; Richardson PJ; Patient L; Patient L; Burbidge S; Festuccia C
Tumour Biol; 2017 Jun; 39(6):1010428317695528. PubMed ID: 28639900
[TBL] [Abstract][Full Text] [Related]
13. Knockdown of CDC2 expression inhibits proliferation, enhances apoptosis, and increases chemosensitivity to temozolomide in glioblastoma cells.
Zhou B; Bu G; Zhou Y; Zhao Y; Li W; Li M
Med Oncol; 2015 Jan; 32(1):378. PubMed ID: 25433945
[TBL] [Abstract][Full Text] [Related]
14. The Small Molecule Ephrin Receptor Inhibitor, GLPG1790, Reduces Renewal Capabilities of Cancer Stem Cells, Showing Anti-Tumour Efficacy on Preclinical Glioblastoma Models.
Gravina GL; Mancini A; Colapietro A; Delle Monache S; Sferra R; Vitale F; Cristiano L; Martellucci S; Marampon F; Mattei V; Beirinckx F; Pujuguet P; Saniere L; Lorenzon G; van der Aar E; Festuccia C
Cancers (Basel); 2019 Mar; 11(3):. PubMed ID: 30871240
[TBL] [Abstract][Full Text] [Related]
15. Interference with PSMB4 Expression Exerts an Anti-Tumor Effect by Decreasing the Invasion and Proliferation of Human Glioblastoma Cells.
Cheng YC; Tsai WC; Sung YC; Chang HH; Chen Y
Cell Physiol Biochem; 2018; 45(2):819-831. PubMed ID: 29414809
[TBL] [Abstract][Full Text] [Related]
16. Mechanism behind the anti-tumour potential of saffron (Crocus sativus L.): The molecular perspective.
Patel S; Sarwat M; Khan TH
Crit Rev Oncol Hematol; 2017 Jul; 115():27-35. PubMed ID: 28602167
[TBL] [Abstract][Full Text] [Related]
17. Intestinal formation of trans-crocetin from saffron extract (Crocus sativus L.) and in vitro permeation through intestinal and blood brain barrier.
Lautenschläger M; Sendker J; Hüwel S; Galla HJ; Brandt S; Düfer M; Riehemann K; Hensel A
Phytomedicine; 2015 Jan; 22(1):36-44. PubMed ID: 25636868
[TBL] [Abstract][Full Text] [Related]
18. MCCK1 enhances the anticancer effect of temozolomide in attenuating the invasion, migration and epithelial-mesenchymal transition of glioblastoma cells in vitro and in vivo.
Liu T; Li A; Xu Y; Xin Y
Cancer Med; 2019 Feb; 8(2):751-760. PubMed ID: 30656846
[TBL] [Abstract][Full Text] [Related]
19. Dual mTORC1/2 blockade inhibits glioblastoma brain tumor initiating cells in vitro and in vivo and synergizes with temozolomide to increase orthotopic xenograft survival.
Luchman HA; Stechishin OD; Nguyen SA; Lun XQ; Cairncross JG; Weiss S
Clin Cancer Res; 2014 Nov; 20(22):5756-67. PubMed ID: 25316808
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms and Antitumor Activity of a Binary EGFR/DNA-Targeting Strategy Overcomes Resistance of Glioblastoma Stem Cells to Temozolomide.
Sharifi Z; Abdulkarim B; Meehan B; Rak J; Daniel P; Schmitt J; Lauzon N; Eppert K; Duncan HM; Petrecca K; Guiot MC; Jean-Claude B; Sabri S
Clin Cancer Res; 2019 Dec; 25(24):7594-7608. PubMed ID: 31540977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
